Biomx Inc

Mimetas is a leading company in Gaithersburg, MD that specializes in drug discovery and preclinical research. They offer a range of resources and support for scientists, partners, and customers worldwide, including peer-reviewed publications, blogs, case studies, webinars, and events. With their innovative 3D tissue culture technology, Mimetas is revolutionizing drug discovery by providing unmatched disease relevance, precision, throughput, and ethical commitment. Their organ-on-a-chip technology recreates physiologically relevant environments on a large scale, making them a trusted partner for global pharmaceutical and biotech companies. Mimetas is dedicated to advancing preclinical predictivity with their human organ models, supporting ADME and safety with enhanced translatability while minimizing reliance on animal models. They offer a wide range of preclinical research applications, including perfused tubules, 3D cell migration, vascularization, and cell-cell interactions. With 10 years of impactful science, Mimetas is committed to leveraging their 3D tissue expertise to provide tailored answers to unique research questions. Their state-of-the-art modeling technologies enable collaborations in drug discovery, prioritization and optimization, and compound analysis. The quality and value they offer have earned them the trust of leading global pharmaceutical and biotech companies.Generated from the website

VLP Therapeutics is a biotech company based in Gaithersburg, MD, specializing in the development of innovative vaccine technologies. Their i-VLP vaccine technology aims to revolutionize the treatment of diseases that currently lack effective treatment, with the potential to make significant contributions to global public health. With a focus on surface antigen display, interior gene delivery, native virus modification, and replicon platforms, VLP Therapeutics is dedicated to creating breakthrough treatments for cancer, infectious diseases, and influenza. They have recently initiated a Phase 3 clinical trial for a self-amplifying replicon RNA COVID-19 booster targeting the Omicron variant, and have secured funding to develop vaccines while establishing an investigational vaccine manufacturing facility.Generated from the website

Orgenesis Inc, based in Germantown, MD, is a pioneering company dedicated to unlocking the full potential of cell and gene therapies (CGTs) in an affordable and accessible format. Their innovative POCare Platform offers a pathway to lower costs and standardized CGTs, aiming to bring advanced therapies to patients globally. With a focus on personalized CGTs, Orgenesis is committed to addressing the world's most challenging diseases. Through collaborations with biotech industry leaders, research institutes, and hospitals, they are revolutionizing drug development and scale-up, making advanced therapies more accessible to those in need.Generated from the website